Original Articles: Asthma and Lower Airway Disease
To add the references below to your reference management program: 1. Download the file; 2. Open your reference management program or EndNote; 3. Select File and import |
173 Articles |
-
The effects of inhaled corticosteroids on healthy airways
Marchi E, Hinks TSC, Richardson M, et al. Allergy. First published: 30 April 2024
Transcriptomic evaluation of skin tape-strips in children with allergic asthma uncovers epidermal barrier dysfunction and asthma-associated biomarkers abnormalities
Del Duca E, Dahabreh D, Kim M, et al. Allergy. First published: 20 February 2024
Identification of allergens from Aspergillus fumigatus—Potential association with lung damage in asthma
Rick E-M, Woolnough K, Richardson M, et al. Allergy. First published: 09 February 2024
Infant lung function and early skin barrier impairment in the development of asthma at age 3 years
Färdig M, Hoyer A, Almqvist C, et al. Allergy. First published: 18 January 2024
Plasma protein signatures of adult asthma
Smilnak GJ, Lee Y, Chattopadhyay A, et al. Allergy. First published: 23 January 2024
Lung function trajectories in a cohort of patients with moderate-to-severe asthma on mepolizumab, omalizumab, or dupilumab
Nopsopon T, Barrett NA, Phipatanakul W, et al. Allergy. First published: 02 January 2024
Sphingolipid classes and the interrelationship with pediatric asthma and asthma risk factors
Chen Y, Checa A, Zhang P, et al. Allergy. First published: 28 November 2023
Periconceptional maternal diet quality and offspring wheeze trajectories: Japan Environment and Children's Study
Okubo H, Nakayama SF, Ohya Y, Japan Environment and Children’s Study Group. Allergy. First published: 18 October 2023
Tezepelumab decreases airway epithelial IL-33 and T2-inflammation in response to viral stimulation in patients with asthma
Sverrild A., Cerps S., Nieto-Fontarigo JJ, et al. Allergy. First published: 17 October 2023
Blood CD62Llow inflammatory eosinophils are related to the severity of asthma and reduced by mepolizumab
Vultaggio, A, Accinno, M, Vivarelli, E, et al. Allergy. First published: 03 October 2023
DEL-1, as an anti-neutrophil transepithelial migration molecule, inhibits airway neutrophilic inflammation in asthma
Jia, M, Fu, H, Jiang, X, et al. Allergy. First published: 08 September 2023
Prediction of adult asthma risk in early childhood using novel adult asthma predictive risk scores
Farhan, AJ, Kothalawala, DM, Kurukulaaratchy, RJ, et al. Allergy. First published: 03 September 2023
Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients
Thomas, D, McDonald, VM, Stevens, S, et al. Allergy. First published: 25 August 2023
Circulating mast cell progenitors increase during natural birch pollen exposure in allergic asthma patients
Alvarado-Vazquez, PA, Mendez-Enriquez, E, Salomonsson, M, et al. Allergy. First published: 24 August 2023
Identification of extracellular vesicle microRNA signatures specifically linked to inflammatory and metabolic mechanisms in obesity-associated low type-2 asthma
Alhamdan, F, Greulich, T, Daviaud, C, et al. Allergy. First published: 24 July 2023
Improved ambient air quality is associated with decreased prevalence of childhood asthma and infancy shortly after weaning is a sensitive exposure window
Chen, T, Shi, S, Li, X, et al. Allergy. First published: 17 July 2023
Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma—Factor analysis
Okada, N, Yamamoto, Y, Oguma, T, et al. Allergy. First published: 17 July 2023
Dupilumab sustains efficacy in patients with moderate-to-severe type 2 asthma regardless of ICS dose
Pavord, ID, Bourdin, A, Papi, A, et al. Allergy. First published: 11 July 2023
Haemophilus influenzae and Moraxella catarrhalis in sputum of severe asthma with inflammasome and neutrophil activation
Versi, A, Ivan, FX, Abdel-Aziz, MI, et al. Allergy. First published:
Glucocorticoids are differentially synthesized along the murine and human respiratory tree
Merk, VM, Renzulli, P, Vrugt, B, et al. Allergy. First published: 12 May 2023
Laundry detergents and surfactants induced eosinophilic airway inflammation by increasing IL-33 expression and activating ILC2s
Saito, K., Orimo, K., Kubo, T., et al. Allergy. First published: 10 May 2023
Dupilumab Improves Long-term Outcomes in Patients With Uncontrolled, Moderate-to-Severe GINA-Based Type 2 Asthma, Irrespective of Allergic Status
Rabe, K.F., Pavord, I.D., Busse, W.W., et al. Allergy. First published: 19 April 2023
Assessment of dupilumab in children with moderate-to-severe type 2 asthma with or without evidence of allergic asthma
Papadopoulos, N.G., Szefler, S.J., Bacharier, L.B., et al. Allergy. First published: 14 April 2023
Epithelium-derived cystatin SN inhibits HDM protease activity in allergic asthma
Yao, L., Yuan, X., Fu, H., et al. Allergy. First published: 07 April 2023
Anti-CD3 Inhibits Circulatory and Tissue-resident Memory CD4 T Cells that Drive Asthma Exacerbations in Mice
Sethi, G.S., Gracias, D.T., Gupta, R.K., et al. Allergy. First published: 23 March 2023
Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both
Pfeffer, P.E., Ali, N., Murray, R., et al. Allergy. First published: 17 March 2023
Trait profiles in difficult-to-treat asthma: clinical impact and response to systematic assessment
Lin, T., Jonathan, P., Denton, E., et al. Allergy. First published: 20 March 2023
Adult asthma with symptomatic eosinophilic inflammation is accompanied by alteration in gut microbiome
Gu, B.-H., Choi, J.-P., Park, T., et al. Allergy. First published: 27 February 2023
C5aR1 activation in mice controls inflammatory eosinophil recruitment and functions in allergic asthma
Wiese, A.V., Duhn, J., Korkmaz, R.Ü., et al. Allergy. First published: 09 February 2023
Global hypomethylation in childhood asthma identified by genome-wide DNA-methylation sequencing preferentially affects enhancer regions
Thürmann, L., Klös, M., Mackowiak, S.D., et al. Allergy. First published: 27 January 2023
Respiratory virome profiles reflect antiviral immune responses
Rubió, J.R., Megremis, S., Pasioti, M., et al. Allergy. First published: 03 January 2023
Intranasal administration of Acinetobacter lwoffii in a murine model of asthma induces IL-6-mediated protection associated with caecal microbiota changes
Alhamwe, B.A., Gao, Z., Alhamdan, F., et al. Allergy. First published: 02 December 2022
Prepregnancy body mass index and risk of childhood asthma
Rosenquist, N.A., Richards, M., Ferber, J.R., et al. Allergy. First published: 27 November 2022
Dietary digestible carbohydrates are associated with higher prevalence of asthma in humans and with aggravated lung allergic inflammation in mice
Musiol, S., Harris, C.P., Karlina, R., et al. Allergy. First published: 24 November 2022
Development of sensitization to peanut and storage proteins and relation to markers of airway and systemic inflammation – a 24-year follow up
Tedner, S.G., Klevebro, S., Bergström, A., Kull, et al. Allergy. First published: 31 October 2022
Biomarkers of asthma relapse and lung function decline in adults with spontaneous asthma remission: a population-based cohort study
Tan, D.J., Lodge, C.J., Walters, E.H., et al. Allergy. First published: 27 October 2022
Furan fatty acid metabolite in newborns predicts risk of asthma
Gürdeniz, G., Kim, M., Brustad, N., et al. Allergy. First published: 17 October 2022
Effect of Haemophilus influenzae, Streptococcus pneumoniae and influenza vaccinations on infections, immune response, and asthma control in preschool children with asthma
Gao, Y.-d., Xepapadaki, P., Cui, Y.-w., et al. Allergy. First published: 13 October 2022
Dual activation of estrogen receptor alpha and glucocorticoid receptor upregulate CRTh2-mediated type 2 inflammation; mechanism driving asthma severity in women?
Vijeyakumaran, M, Jawhri, MA, Fortunato, J, et al. Allergy. First published: 07 October 2022
The maternal prenatal and offspring early-life gut microbiome of childhood asthma phenotypes
Lee-Sarwar, K.A., Chen, Y.-C., Chen, Y.Y., et al. Allergy. First published: 15 September 2022
circS100A11 enhances M2a macrophage activation and lung inflammation in children with asthma
Liang, Q., Fu, J., Wang, X., et al. Allergy. First published: 14 September 2022
Obesity in women with asthma: baseline disadvantage plus greater small-airway responsiveness
Bourdin, A., Bommart, S., Marin, G., et al. Allergy. First published: 07 September 2022
IL1RAP expression and the enrichment of IL-33 activation signatures in severe neutrophilic asthma
Badi, Y.E., Salcman, B., Taylor, A., et al. Allergy. First published: 20 August 2022
Serum exosome inflamma-miRs are surrogate biomarkers for asthma phenotype and severity
Vázquez-Mera, S., Martelo-Vidal, L., Miguéns-Suárez, P., et al. Allergy. First published: 16 August 2022
Different aspects of severe asthma in real life: Role of Staphylococcus aureus enterotoxins and correlation to comorbidities and disease severity
Caruso, C, Colantuono, S, Ciasca, G, et al. Allergy. First published: 03 August 2022
Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate-to-severe type 2 asthma
Papi, A., Corren, J., Castro, M., et al. Allergy. First published: 28 July 2022
A common IL-4 receptor variant promotes asthma severity via a Treg cell GRB2-IL-6-Notch4 circuit
Benamar, M, Harb, H, Chen, Q, et al. Allergy. First published: 16 July 2022
Maternal prenatal immunity, neonatal trained immunity, and early airway microbiota shape childhood asthma development
DeVries, A, McCauley, K, Fadrosh, D, et al. Allergy. First published: 16 July 2022
Relationship between inflammatory status and microbial composition in severe asthma and during exacerbation
Diver, S., Haldar, K., McDowell, P.J., et al. Allergy. First published: 01 July 2022
Proteomics endotyping of infants with severe bronchiolitis and risk of childhood asthma
Ooka, T, Raita, Y, Fujiogi, M, et al. Allergy. First published: 27 May 2022
Pollen exposure is associated with risk of respiratory symptoms during the first year of life
Gisler, A., Eeftens, M., de Hoogh, K., et al. Allergy. First published: 18 March 2022
Airway remodelling rather than cellular infiltration characterises both type2 cytokine biomarker-high and -low severe asthma
Khalfaoui, L., Symon, F.A., Couillard, S., et al. Allergy. First published: 17 May 2022
Nontypeable Haemophilus influenzae infection of pulmonary macrophages drives neutrophilic inflammation in severe asthma
Ackland, J., Barber, C., Heinson, A., et al. Allergy. First published: 16 May 2022
Poultry exposure and environmental protection against asthma in rural children
Xing, Y., Wang, M.H., Leung, T.-F., et al. Allergy. First published: 09 May 2022
Cost-effectiveness analysis of house dust mite allergen immunotherapy in children with allergic asthma
Farraia, M, Paciência, I, Castro Mendes, F, et al. Allergy. First published: 22 April 2022
Intranasal administration of a VLP-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concern
Rothen, D.A., Krenger, P.S., Nonic, A., et al. Allergy. First published: 11 April 2022
Activation of succinate receptor 1 boosts human mast cell reactivity and allergic bronchoconstriction
Tang, X., Rönnberg, E., Säfholm, J., et al. Allergy. First published: 04 February 2022
House dust mite sensitization and exposure affects bronchial epithelial anti-microbial response to viral stimuli in patients with asthma
Cerps, S., Sverrild, A., Ramu, S., et al. Allergy. First published: 03 February 2022
Differential effects of lung inflammation on insulin resistance in humans and mice
Karlina, R., Flexeder, C., Musiol, S., et al. Allergy. First published: 20 January 2022
TFEB signaling attenuates NLRP3-driven inflammatory responses in severe asthma
Theofani, E., Semitekolou, M., Samitas, K., et al. Allergy. First published: 17 January 2022
Thrombin cleaves IL-33 and modulates IL-33-activated allergic lung inflammation
Huang, Y., Li, X., Zhu, L., Huang, C., et al. Allergy. First published: 07 January 2022
Serum periostin among infants with severe bronchiolitis and risk of developing asthma: A prospective multicenter cohort study
Nanishi, M., Fujiogi, M., Freishtat, R.J., et al. Allergy. First published: 09 January 2022
Baseline type 2 biomarker levels and response to tezepelumab in severe asthma
Corren, J., Pham, T.-H., Gil, E.G., et al. Allergy. First published: 16 December 2021
Understanding uncontrolled severe allergic asthma by integration of omic and clinical data
Delgado-Dolset, MI, Obeso, D, Rodríguez-Coira, J, et al. Allergy. First published: 28 November 2021
Role of IL-18-transformed CD274-expressing eosinophils in promoting airway obstruction in experimental asthma
Mishra, A, Majid, D, Kandikattu, HK, Yadavalli, CS, Upparahalli Venkateshaiah, S. Allergy. First published: 20 November 2021
Large-scale provocation studies identify maladaptive responses to ubiquitous aeroallergens as a correlate of severe allergic rhinoconjunctivitis and asthma
Smith, A.M., Ramirez, R.M., Harper, N., et al. Allergy. First published: 04 October 2021
Glutamine deficiency shifts the asthmatic state toward neutrophilic airway inflammation
Kim, J-M, Im, YN, Chung, Y-J, et al. Allergy. First published: 03 October 2021
Physical activity in asthma control and its immune modulatory effect in asthmatic preschoolers
Maurer, D.J., Liu, C., Xepapadaki, P., et al. Allergy. First published: 21 September 2021
Single base editing of rs12603332 on chromosome 17q21 with a cytosine base editor regulates ORMDL3 and ATF6α expression
Weng, N., Miller, M., Pham, A.K., Komor, A.C. and Broide, D.H. Allergy. First published: 15 September 2021
An altered sputum macrophage transcriptome contributes to the neutrophilic asthma endotype
Fricker, M., Qin, L., Sánchez-Ovando, S., et al. Allergy. First published: 12 September 2021
Trajectories of asthma and allergy symptoms from childhood to adulthood
Forster, F, Ege, MJ, Gerlich, J, et al. Allergy. First published: 02 September 2021
IL-37 regulates allergic inflammation by counterbalancing pro-inflammatory IL-1 and IL-33
Schröder, A, Lunding, LP, Zissler, UM, et al. Allergy. First published: 30 August 2021
Separation of the CaV1.2-CaV1.3 calcium channel duo prevents type-2 allergic airway inflammation
Giang, N., Mars, M., Moreau, M., et al. Allergy. First published: 28 June 2021
Experimental rhinovirus infection induces an antiviral response in circulating B cells which is dysregulated in patients with asthma
Wirz, O.F., Jansen, K., Satitsuksanoa, P., et al. Allergy. First published: 25 June 2021
Trajectories of IgE sensitization to allergen molecules from childhood to adulthood and respiratory health in the EGEA cohort
Siroux, V., Boudier, A., Bousquet, J., et al. Allergy. First published: 25 June 2021
Asthma phenotypes, associated comorbidities, and long-term symptoms in COVID-19
Eggert, L.E., He, Z., Collins, W., et al.Allergy. First published: 03 June 2021
The maternal diet index in pregnancy is associated with offspring allergic diseases: the Healthy Start study
Venter, C, Palumbo, MP, Glueck, DH, et al.Allergy. First published: 22 May 2021
Epigenetic regulation of epithelial dectin-1 through an IL-33-STAT3 axis in allergic disease
Yong, H.M., Gour, N., Sharma, D., Khalil, S.M., Lane, A.P. and Lajoie, S. Allergy. First published: 12 May 2021
Benralizumab improves symptoms of patients with severe, eosinophilic asthma with a diagnosis of nasal polyposis
Canonica, G.W., Harrison, T.W., Chanez, P., et al. Allergy. First published: 12 May 2021
Glucagon-like peptide-1 receptor agonist inhibits aeroallergen-induced activation of ILC2 and neutrophilic airway inflammation in obese mice
Toki, S., Newcomb, D.C., Printz, R.L., et al. Allergy. First published: 06 May 2021
Neonatal airway immune profiles and asthma and allergy endpoints in childhood
Chawes, B.L., Wolsk, H.M., Carlsson, C.J., et al. Allergy. First published: 16 April 2021
Biologics and airway remodeling in severe asthma
Varricchi G., Ferri S., Pepys J., et al. Allergy. 2022;77(12):3538-3552
Prevalence and early-life risk factors of school-age allergic multimorbidity: The EuroPrevall-iFAAM birth cohort
Sigurdardottir, ST, Jonasson, K, Clausen, M, et al. Allergy. 2021; 76: 2855– 2865
Effect of intranasal corticosteroid treatment on allergen-induced changes in group 2 innate lymphoid cells in allergic rhinitis with mild asthma
Xie, Y., Ju, X., Beaudin, S., et al. Allergy. 2021; 76: 2797-2808
Real-life impact of COVID-19 pandemic lockdown on the management of pediatric and adult asthma: A survey by the EAACI Asthma Section
Eguiluz-Gracia, I., van den Berge, M., Boccabella, C., et al. Allergy. 2021; 76: 2776-2784
Impact of early life geohelminths on wheeze, asthma and atopy in Ecuadorian children at 8 years
Cooper, P.J., Chis Ster, I., Chico, M.E., et al. Allergy.2021; 76: 2765-2775
Increased day-to-day fluctuations in exhaled breath profiles after a rhinovirus challenge in asthma
Lammers, A., Brinkman, P., te Nijenhuis, L.H., et al. Allergy.2021; 76: 2488-2499
Epithelial expression and role of secreted STC1 on asthma airway hyperresponsiveness through calcium channel modulation
Xu, J., Meng, Y., Jia, M., et al. Allergy.2021; 76: 2475-2487
Sputum TNF markers are increased in neutrophilic and severe asthma and are reduced by azithromycin treatment
Niessen, N.M., Gibson, P.G., Baines, K.J., et al. Allergy. 2021; 76: 2090-2101
Molecular markers of type 2 airway inflammation are similar between eosinophilic severe asthma and eosinophilic COPD
Fricker, M., McDonald, V.M., Winter, N.A., et al. Allergy.2021; 76: 2079-2089
Peripheral airways type 2 inflammation, neutrophilia and microbial dysbiosis in severe asthma
Azim, A., Green, B., Lau, L., et al. Allergy. 2021; 76: 2070-2078
Comparative analysis of the role of mast cells in murine asthma models using Kit-sufficient mast cell-deficient animals
Pohlmeier, L., Sonar, S.S., Rodewald, H.-R., Kopf, M. and Tortola, L. Allergy.2021; 76: 2030-2043
Mast cell-derived serotonin enhances methacholine-induced airway hyperresponsiveness in house dust mite-induced experimental asthma
Mendez-Enriquez, E., Alvarado-Vazquez, P.A., Abma, W., et al. Allergy.2021; 76: 2057-2069
Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multinational cohort
Papadopoulos, N.G., Mathioudakis, A.G., Custovic, A., et al. Allergy. 2021; 76: 1765-1775
Airway immune mediator levels during asthma-like symptoms in young children and their possible role in response to azithromycin
Carlsson, CJ, Rasmussen, MA, Pedersen, SB, et al. Allergy. 2021; 76: 1754– 1764
Is short-term exposure to grass pollen adversely associated with lung function and airway inflammation in the community?
Idrose, NS, Tham, RCA, Lodge, CJ, et al. Allergy. 2021; 76: 1136– 1146
RAGE and TLR4 differentially regulate airway hyperresponsiveness: Implications for COPD
Allam, VSRR, Faiz, A, Lam, M, et al. Allergy. 2021; 76: 1123– 1135
Sputum macrophage diversity and activation in asthma: Role of severity and inflammatory phenotype
Tiotiu, A, Zounemat Kermani, N, Badi, Y, et al. Allergy. 2021; 76: 775– 788
Circulating microRNA-15b-5p as a biomarker for asthma-COPD overlap
Hirai, K, Shirai, T, Shimoshikiryo, T, et al. Allergy. 2021; 76: 766– 774
Distinct effects of asthma and COPD comorbidity on disease expression and outcome in patients with COVID-19
Song, J, Zeng, M, Wang, H, et al. Allergy. 2021; 76: 483– 496
The role of peripheral blood eosinophil counts in COVID-19 patients
Xie, G, Ding, F, Han, L, Yin, D, Lu, H, Zhang, M. Allergy. 2021; 76: 471– 482
The neighbourhood natural environment is associated with asthma in children: A birth cohort study
Rufo J. C., Paciência I., Hoffimann E., Moreira A., Barros H., Ribeiro A. I. Allergy. 2021; 76: 348– 358
Th2 cell markers in peripheral blood increase during an acute asthma exacerbation
Palikhane N. S. et al. Allergy. 2021; 76:281-290
Dupilumab is effective in type 2-high asthma patients receiving high-dose inhaled corticosteroids at baseline
Bourdin, A, Papi, AA, Corren, J, et al. Allergy. 2021; 76: 269– 280
Estrogen receptor-α signaling increases allergen-induced IL-33 release and airway inflammation
Cephus J.-Y., Gandhi, V.D., Shah, R. et al. Allergy. 2021; 76: 255-268
Clinical correlates of rhinovirus infection in preschool asthma
Jartti, T, Liimatainen, U, Xepapadaki, P, et al. Allergy. 2021; 76: 247– 254
Cross-reactive carbohydrate determinant-specific IgE obscures true atopy and exhibits ⍺ -1,3-fucose epitopespecific inverse associations with asthma
Nkurunungi, G, Mpairwe, H, Versteeg, SA, et al. Allergy. 2021; 76: 233– 246
Characteristics of specialist-diagnosed asthma-COPD overlap in severe asthma: Observations from the Korean Severe Asthma Registry (KoSAR)
Lee H., Kim, S.H., Käm, B.K. et al. Allergy. 2021; 76:233-232
Impaired airway epithelial cell wound-healing capacity is associated with airway remodelling following RSV infection in severe preschool wheeze
Andersson, CK, Iwasaki, J, Cook, J, et al. Allergy. 2020; 75: 3195– 3207
ST2 expression and release by the bronchial epithelium is downregulated in asthma
Kaur, D, Chachi, L, Gomez, E, et al. Allergy. 2020; 75: 3184– 3194
iTRAQ-based proteomic analysis reveals potential serum biomarkers of allergic and nonallergic asthma
Nieto-Fontarigo, JJ, González-Barcala, FJ, Andrade-Bulos, LJ, et al. Allergy. 2020; 75: 3171– 3183
Lysophosphatidylserine induces eosinophil extracellular trap formation and degranulation: Implications in severe asthma
Kim, HJ, Sim, MS, Lee, DH, et al. Allergy. 2020; 75: 3159– 3170
Metabolic shift favoring C18:0 ceramide accumulation in obese asthma
Choi, Y, Kim, M, Kim, SJ, Yoo, H-J, Kim, S-H, Park, H-S. Allergy. 2020; 75: 2858– 2866
The 2016 Melbourne thunderstorm asthma epidemic: Risk factors for severe attacks requiring hospital admission
Chiu, C-Y, Chou, H-C, Chang, L-C, et al. Allergy. 2020; 75: 2846– 2857
Tnfaip3 expression in pulmonary conventional type 1 Langerin-expressing dendritic cells regulates T helper 2-mediated airway inflammation in mice
Vroman, H, van Uden, D, Bergen, IM, et al. Allergy. 2020; 75: 2587– 2598
IL33 contributes to diesel pollution-mediated increase in experimental asthma severity
Brandt, EB, Bolcas, PE, Ruff, BP, Khurana Hershey, GK. Allergy. 2020; 75: 2254– 2266
Orally applied bacterial lysate in infants at risk for atopy does not prevent atopic dermatitis, allergic rhinitis, asthma or allergic sensitization at school age: Follow-up of a randomized trial
Roßberg, S, Keller, T, Icke, K, et al. Allergy. 2020; 75: 2020– 2025
IL-1β prevents ILC2 expansion, type 2 cytokine secretion, and mucus metaplasia in response to early-life rhinovirus infection in mice
Han, M, Ishikawa, T, Bermick, JR, et al. Allergy. 2020; 75: 2005– 2019
Ceramide/sphingosine-1-phosphate imbalance is associated with distinct inflammatory phenotypes of uncontrolled asthma
Kim, S-H, Jung, H-W, Kim, M, et al. Allergy. 2020; 75: 1991– 2004
Antibiotic use during pregnancy increases offspring asthma severity in a dose-dependent manner
Alhasan, MM, Cait, AM, Heimesaat, MM, et al. Allergy. 2020; 75: 1979– 1990
Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air(®) App
Bédard, A, Antó, JM, Fonseca, JA, et al. Allergy. 2020; 75: 1672– 1688
Novel tobacco products including electronic cigarette and heated tobacco products increase risk of allergic rhinitis and asthma in adolescents: Analysis of Korean youth survey
Chung, SJ, Kim, B-K, Oh, JH, et al. Allergy. 2020; 75: 1640– 1648
Human volatilome analysis using eNose to assess uncontrolled asthma in a clinical setting
Farraia, M, Cavaleiro Rufo, J, Paciência, I, et al. Allergy. 2020; 75: 1630– 1639
Therapeutic and prophylactic deletion of IL-4Ra-signaling ameliorates established ovalbumin induced allergic asthma
Khumalo, J, Kirstein, F, Scibiorek, M, Hadebe, S, Brombacher, F. Allergy. 2020; 75: 1347– 1360
The presence of Aspergillus fumigatus in asthmatic airways is not clearly related to clinical disease severity
Sullivan, AF, Hunt, EB, Ward, C, et al. Allergy. 2020; 75: 1146– 1154
Macrophage-derived progranulin promotes allergen-induced airway inflammation
Choi, J-P, Park, SY, Moon, K-A, et al. Allergy. 2020; 75: 1133– 1145
Early pubertal maturation and risk of childhood asthma: A mendelian randomization and longitudinal study
Chen, Y-C, Fan, H-Y, Yang, C, Lee, YL. Allergy. 2020; 75: 892– 900
A critical role for c-Myc in group 2 innate lymphoid cell activation
Ye, L, Pan, J, Liang, M, et al. Allergy. 2020; 75: 841– 852.
Subphenotypes of nonsteroidal antiinflammatory disease-exacerbated respiratory disease identified by latent class analysis
Celejewska-Wójcik, N, Wójcik, K, Ignacak-Popiel, M, et al. Allergy. 2020; 75: 831– 840
Pulmonary IL-33 orchestrates innate immune cells to mediate respiratory syncytial virus-evoked airway hyperreactivity and eosinophilia
Wu, Y-H, Lai, AC-Y, Chi, P-Y, et al. Allergy. 2020; 75: 818– 830
Sputum microbiomic clustering in asthma and chronic obstructive pulmonary disease reveals a Haemophilus-predominant subgroup
Diver, S, Richardson, M, Haldar, K, et al. Allergy. 2020; 75: 808– 817
Acid sphingomyelinase regulates T(H) 2 cytokine release and bronchial asthma
Böll, S, Ziemann, S, Ohl, K, et al. Allergy. 2020; 75: 603– 615
The moderating role of allergy immunotherapy in asthma progression: Results of a population-based cohort study
Schmitt, J, Wüstenberg, E, Küster, D, Mücke, V, Serup-Hansen, N, Tesch, F. Allergy. 2020; 75: 596– 602
Aggravation of asthmatic inflammation by chlorine exposure via innate lymphoid cells and CD11c(intermediate) macrophages
Shim, J-S, Lee, H-S, Park, D-E, et al. Allergy. 2020; 75: 381– 391
Blood eosinophil count and airway epithelial transcriptome relationships in COPD versus asthma
George, L, Taylor, AR, Esteve-Codina, A, et al. Allergy. 2020; 75: 370– 380
Colony-stimulating factor 1 and its receptor are new potential therapeutic targets for allergic asthma
Moon, H-G, Kim, S-J, Lee, MK, et al. Allergy. 2020; 75: 357– 369
Human airway epithelial extracellular vesicle miRNA signature is altered upon asthma development
Bartel, S, La Grutta, S, Cilluffo, G, et al. Allergy. 2020; 75: 346– 356
PAG1 limits allergen-induced type 2 inflammation in the murine lung
Ullah, MA, Vicente, CT, Collinson, N, et al. Allergy. 2020; 75: 336– 345
The first year of treatment predicts the prognosis of asthma over 25 y-A prospective study
Kauppinen, R, Vilkka, V, Sintonen, H, Hedman, J. Allergy. 2020; 75: 75– 83
Basophil degranulation in response to IgE ligation is controlled by a distinctive circadian clock in asthma
Spadaro, G, Giurato, G, Stellato, C, Marone, G, Casolaro, V. Allergy. 2020; 75: 158– 168
Impact of high-altitude therapy on type-2 immune responses in asthma patients
Boonpiyathad, T, Capova, G, Duchna, H-W, et al. Allergy. 2020; 75: 84– 94
Risk of adult-onset asthma increases with the number of allergic multimorbidities and decreases with age
Toppila-Salmi, S, Chanoine, S, Karjalainen, J, Pekkanen, J, Bousquet, J, Siroux, V. Allergy. 2019; 74: 2406– 2416
Oral corticosteroid use, morbidity and mortality in asthma: A nationwide prospective cohort study in Sweden
Ekström, M, Nwaru, BI, Hasvold, P, Wiklund, F, Telg, G, Janson, C. Allergy. 2019; 74: 2181– 2190
Determination of the minimally important difference in a nasal symptom score in house dust mite allergy
Devillier, P, Brüning, H, Bergmann, K-C. Allergy. 2019; 74: 2191– 2198
Pollen exposure at birth and adolescent lung function, and modification by residential greenness
Lambert, KA, Lodge, C, Lowe, AJ, et al. Allergy. 2019; 74: 1977– 1984
Google trends and pollen concentrations in allergy and airway diseases in France
Bousquet, J, Onorato, GL, Oliver, G, et al. Allergy. 2019; 74: 1910– 1919
Eosinophils capture viruses, a capacity that is defective in asthma
Sabogal Piñeros, YS, Bal, SM, Dijkhuis, A, et al. Allergy. 2019; 74: 1898– 1909
The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma
Chapman, KR, Albers, FC, Chipps, B, et al. Allergy. 2019; 74: 1716– 1726
Changes in the prevalence of asthma and respiratory symptoms in western Sweden between 2008 and 2016
Borna, E, Nwaru, BI, Bjerg, A, et al. Allergy. 2019; 74: 1703– 1715
Lung disease in STAT3 hyper-IgE syndrome requires intense therapy
Kröner, C, Neumann, J, Ley-Zaporozhan, J, et al. Allergy. 2019; 74: 1691– 1702
Benzo(a)pyrene facilitates dermatophagoides group 1 (Der f 1)-induced epithelial cytokine release through aryl hydrocarbon receptor in asthma
Wang, E, Liu, X, Tu, W, et al. Allergy. 2019; 74: 1675– 1690
The Patient Needs in Asthma Treatment (NEAT) questionnaire: Further evidence on its psychometric properties
Schreitmüller, J, Apfelbacher, C, Sheikh, A, Loerbroks, A. Allergy. 2019; 74: 1511– 1521
Bronchial asthma triggered by house dust mites in patients with local allergic rhinitis
Campo, P, Eguiluz-Gracia, I, Plaza-Serón, MC, et al. Allergy. 2019; 74: 1502– 1510
Immunotherapy with grass pollen tablets reduces medication dispensing for allergic rhinitis and asthma: A retrospective database study in France
Devillier, P, Molimard, M, Ansolabehere, X, et al. Allergy. 2019; 74: 1317– 1326
Mobile health tools for the management of chronic respiratory diseases
Sleurs, K, Seys, SF, Bousquet, J, et al. Allergy. 2019; 74: 1292- 1306
Exposure to indoor endocrine-disrupting chemicals and childhood asthma and obesity
Paciência, I, Cavaleiro Rufo, J, Silva, D, et al. Allergy. 2019; 74: 1277– 1291
Mast cell chymase impairs bronchial epithelium integrity by degrading cell junction molecules of epithelial cells
Zhou, X, Wei, T, Cox, CW, Jiang, Y, Roche, WR, Walls, AF. Allergy. 2019; 74: 1266– 1276
Data-driven adult asthma phenotypes based on clinical characteristics are associated with asthma outcomes twenty years later
Boudier, A, Chanoine, S, Accordini, S, et al. Allergy. 2019; 74: 953– 963
Disentangling the heterogeneity of allergic respiratory diseases by latent class analysis reveals novel phenotypes
Amaral, R, Bousquet, J, Pereira, AM, et al. Allergy. 2019; 74: 698– 708
Chitinase 3-like 1 protein plays a critical role in respiratory syncytial virus-induced airway inflammation
Kim, MJ, Shim, DH, Cha, H-R, et al. Allergy. 2019; 74: 685– 697
Prenatal particulate matter affects new asthma via airway hyperresponsiveness in school children
Yang, S-I, Lee, S-Y, Kim, H-B, et al. Allergy. 2019; 74: 675– 684
Osteopontin protects against pneumococcal infection in a murine model of allergic airway inflammation
Kasetty, G, Bhongir, RKV, Papareddy, P, et al. Allergy. 2019; 74: 663– 674
Targeting the ICOS/ICOS-L pathway in a mouse model of established allergic asthma disrupts T follicular helper cell responses and ameliorates disease
Uwadiae, FI, Pyle, CJ, Walker, SA, Lloyd, CM, Harker, JA. Allergy. 2019; 74: 650– 662
FoxO1 is a critical regulator of M2-like macrophage activation in allergic asthma
Chung, S, Kim, JY, Song, M-A, et al. Allergy. 2019; 74: 535– 548
Pulmonary function and bronchial reactivity 4 years after the first virus-induced wheezing
Leino, A, Lukkarinen, M, Turunen, R, et al. Allergy. 2019; 74: 518– 526
Exhaled breath condensate volatilome allows sensitive diagnosis of persistent asthma
Cavaleiro Rufo, J, Paciência, I, Mendes, FC, et al. Allergy. 2019; 74: 527– 534
Asthma diagnosis using integrated analysis of eosinophil microRNAs
Rodrigo-Muñoz, JM, Cañas, JA, Sastre, B, et al. Allergy. 2019; 74: 507– 517
Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma
Voorham, J, Xu, X, Price, DB, et al. Allergy. 2019; 74: 273– 283
Artemisia pollen allergy in China: Component-resolved diagnosis reveals allergic asthma patients have significant multiple allergen sensitization
Gao, Z, Fu, W-Y, Sun, Y, et al. Allergy. 2019; 74: 284– 293
Are high- and low-molecular-weight sensitizing agents associated with different clinical phenotypes of occupational asthma?
Vandenplas, O, Godet, J, Hurdubaea, L, et al. Allergy. 2019; 74: 261– 272
The 2016 Melbourne thunderstorm asthma epidemic: Risk factors for severe attacks requiring hospital admission
Hew, M, Lee, J, Susanto, NH, et al. Allergy. 2019; 74: 122– 130
Mucin 1 deficiency mediates corticosteroid insensitivity in asthma
Milara, J, Morell, A, de Diego, A, Artigues, E, Morcillo, E, Cortijo, J. Allergy. 2019; 74: 111– 121
Intranasal administration of probiotic Lactobacillus rhamnosus GG prevents birch pollen-induced allergic asthma in a murine model
Spacova, I, Petrova, MI, Fremau, A, et al. Allergy. 2019; 74: 100– 110
RAGE-dependent VCAM-1 expression in the lung endothelium mediates IL-33-induced allergic airway inflammation
Perkins, TN, Oczypok, EA, Milutinovic, PS, Dutz, RE, Oury, TD. Allergy. 2019; 74: 89– 99
Surfactant protein D alleviates eosinophil-mediated airway inflammation and remodeling in patients with aspirin-exacerbated respiratory disease
Choi, Y, Lee, D-H, Trinh, HKT, et al. Allergy. 2019; 74: 78– 88